Nerlynx (neratinib) for the Treatment of Breast Cancer

Nerlynx ™ (neratinib) is a tyrosine kinase inhibitor indicated for the treatment of adult patients with early-stage HER2-overexpressed or amplified breast cancer.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news